Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus

Detalles Bibliográficos
Autores principales: Radellini, Stefano, Vigneri, Enrica, Guarnotta, Valentina, Panto, Felicia, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385013/
https://www.ncbi.nlm.nih.gov/pubmed/34313955
http://dx.doi.org/10.1007/s13300-021-01119-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385013/
https://www.ncbi.nlm.nih.gov/pubmed/34313955
http://dx.doi.org/10.1007/s13300-021-01119-6

Ejemplares similares